Synaffix licenses CliCr chemistry from Cristal Therapeutics

Truly emboldened by the signed license agreement with Synaffix as it underscores the potential of our unique CliCr® technology! This represents an important milestone in the execution of our strategy to commercialize CliCr® in different fields of diagnostic and therapeutic bioconjugates. Please contact us in case of any interest! Synaffix license CliCr Cristal Therapeutics

BIO Digital

June 14-17 2021 BIO Digital Digital

BIO Europe Spring

March 22-25 2021 BIO Europe Spring Digital

LSX World Congress

February 01-05 2021 LSX World Congress Digital

Biotech Showcase

January 11-13 2021 Biotech Showcase Digital

BIO Europe

October 26-29 2020 BIO-Europe Digital

Oncology Virtual Partnering

September 22-24 2020 Oncology Virtual Partnering Digital

BioPharm America

September 21-24 2020 BioPharm America Digital